ITMI20022745A1 - Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. - Google Patents
Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione.Info
- Publication number
- ITMI20022745A1 ITMI20022745A1 IT002745A ITMI20022745A ITMI20022745A1 IT MI20022745 A1 ITMI20022745 A1 IT MI20022745A1 IT 002745 A IT002745 A IT 002745A IT MI20022745 A ITMI20022745 A IT MI20022745A IT MI20022745 A1 ITMI20022745 A1 IT MI20022745A1
- Authority
- IT
- Italy
- Prior art keywords
- cytostatic
- procedure
- production
- hyaluronic acid
- mixed esters
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
- C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
- C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
- C08B37/0072—Hyaluronic acid, i.e. HA or hyaluronan; Derivatives thereof, e.g. crosslinked hyaluronic acid (hylan) or hyaluronates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002745A ITMI20022745A1 (it) | 2002-12-23 | 2002-12-23 | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
| EP03785916A EP1578803A1 (en) | 2002-12-23 | 2003-12-22 | Mixed esters of hyaluronic acid with retinoic and butyric acids |
| US10/540,939 US20060074048A1 (en) | 2002-12-23 | 2003-12-22 | Mixed esters of hyaluronic acid with retinoic and butyric acids |
| CA002529816A CA2529816A1 (en) | 2002-12-23 | 2003-12-22 | Mixed esters of hyaluronic acid with retinoic and butyric acids |
| AU2003294936A AU2003294936A1 (en) | 2002-12-23 | 2003-12-22 | Mixed esters of hyaluronic acid with retinoic and butyric acids |
| PCT/EP2003/014732 WO2004056877A1 (en) | 2002-12-23 | 2003-12-22 | Mixed esters of hyaluronic acid with retinoic and butyric acids |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002745A ITMI20022745A1 (it) | 2002-12-23 | 2002-12-23 | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20022745A1 true ITMI20022745A1 (it) | 2004-06-24 |
Family
ID=32676860
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT002745A ITMI20022745A1 (it) | 2002-12-23 | 2002-12-23 | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20060074048A1 (it) |
| EP (1) | EP1578803A1 (it) |
| AU (1) | AU2003294936A1 (it) |
| CA (1) | CA2529816A1 (it) |
| IT (1) | ITMI20022745A1 (it) |
| WO (1) | WO2004056877A1 (it) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20040347A1 (it) * | 2004-02-26 | 2004-05-26 | Pharma Medical Ltd | Nuovo farmaco di associazione |
| ZA200800901B (en) | 2005-07-14 | 2010-05-26 | Takeda San Diego Inc | Histone deacetylase inhibitors |
| IE20060049A1 (en) * | 2006-01-25 | 2007-08-08 | Eurand Pharmaceuticals Ltd | A novel drug delivery system: use of hyaluronic acid as a carrier moleclue for different classes of therapeutic active agents |
| CA2686558A1 (fr) * | 2007-05-11 | 2008-12-11 | Galderma Research & Development | Preparations pharmaceutiques ou cosmetiques pour application topique et/ou parenterale, leurs procedes de preparation, et leurs utilisations |
| ITMI20072237A1 (it) * | 2007-11-27 | 2009-05-28 | Sigea Srl | Esteri misti butirrico-formico di polisaccaridi acidi, loro preparazione ed uso come dermocosmetici |
| CZ301555B6 (cs) | 2008-11-06 | 2010-04-14 | Cpn S. R. O. | Zpusob prípravy DTPA sítovaných derivátu kyseliny hyaluronové a jejich modifikace |
| CZ304654B6 (cs) | 2012-11-27 | 2014-08-20 | Contipro Biotech S.R.O. | Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití |
| US10618982B2 (en) * | 2015-01-13 | 2020-04-14 | Bmg Pharma S.P.A. | Process in water for the preparation of butyric esters of hyaluronic acid sodium salt |
| MA41912A (fr) * | 2015-04-07 | 2018-02-13 | Hyalblue S R L | Esters de glycosaminoglycane, procédés pour leur préparation et leur utilisation dans des formulations à usage ophtalmique |
| CN105418803A (zh) * | 2015-12-30 | 2016-03-23 | 山东天晟生物科技有限公司 | 一种透明质酸的酯化方法 |
| CN111253504A (zh) * | 2020-03-19 | 2020-06-09 | 上海缓释新材料科技有限公司 | 一种无毒副作用的维生素a衍生物及其制备方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2282596B (en) * | 1993-10-06 | 1998-04-15 | Ciba Geigy Ag | Water-soluble retinoids |
| IT1286510B1 (it) * | 1996-11-29 | 1998-07-15 | Cooperativa Centro Ricerche Po | Esteri butirrici ad attivita' antiproliferativa e composizioni farmaceutiche che li contengono |
| ITTS20010017A1 (it) * | 2001-07-17 | 2003-01-17 | Ct Ricerche Polytech Soc Coop | Esteri polisaccaridici di acido retinoico. |
-
2002
- 2002-12-23 IT IT002745A patent/ITMI20022745A1/it unknown
-
2003
- 2003-12-22 US US10/540,939 patent/US20060074048A1/en not_active Abandoned
- 2003-12-22 WO PCT/EP2003/014732 patent/WO2004056877A1/en not_active Application Discontinuation
- 2003-12-22 AU AU2003294936A patent/AU2003294936A1/en not_active Abandoned
- 2003-12-22 CA CA002529816A patent/CA2529816A1/en not_active Abandoned
- 2003-12-22 EP EP03785916A patent/EP1578803A1/en not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| EP1578803A1 (en) | 2005-09-28 |
| WO2004056877A1 (en) | 2004-07-08 |
| CA2529816A1 (en) | 2004-07-08 |
| US20060074048A1 (en) | 2006-04-06 |
| AU2003294936A1 (en) | 2004-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003202259A1 (en) | Lipid compositions, production thereof and of esters | |
| ITMI20022745A1 (it) | Esteri misti dell'acido ialuronico ad attivita' citostatica e prodifferenziante e procedimento per la loro produzione. | |
| DE50201306D1 (de) | Verfahren zur kontinuierlichen herstellung inhalierfähiger arzneistoffe | |
| ZA200409940B (en) | Novel prodrugs of 1-methyl-2-(4-amidinopheylaminomethyl)-benzimadozol-5-yl-carboxylic acid-(N-2-pyridil-N-2-hydroxycarbonlethyl)-amide, production and uses thereof as medicaments | |
| ITMI20000559A0 (it) | Esteri polisaccaridici di n-derivati di acido glutammico | |
| AU2003301584A8 (en) | Enzyme-catalyzed transesterifications of pendant carboxylic acid groups | |
| IL169096A (en) | Production process of gamma-cyhalothrin and intermediate | |
| WO2008023003A8 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| AU2003242002A8 (en) | Method for optimising the production technology of rolled products | |
| ITMI20010077A0 (it) | Procedimento per la produzione dell'imipenem | |
| IL178906A0 (en) | 7H-PYRROLO[2,3-d]PYRIMIDINE DERIVATIVES, AS WELL AS THEIR THERAPEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL PREPARATIONS CONTAINING THEM AND PROCESS FOR PRODUCTION THE ACTIVE AGENT | |
| AU2003282375A1 (en) | Pharmaceutical compositions and process of production thereof | |
| ITMI20002187A0 (it) | Processo per la produzione dell'acido r(+) -lipico | |
| ITMI20011132A1 (it) | Procedimento per la preparazione dell'acido 1-amminometil-1-cicloesanacetico | |
| ITMI20040013A1 (it) | Procedimento per la preparazione di esteri dell'acido -met-acrilico | |
| AU2003275918A1 (en) | Method for the production of biocompatible polyurethanes | |
| ITMI20040937A1 (it) | Esteri dell'acido butirrico e processo per la loro preparazione | |
| AU2003292209A1 (en) | Method for the production of optically active dihydropyrones | |
| AU2003241288A1 (en) | Production of stable collagens | |
| ITMI20021168A1 (it) | Procedimento per la preparazione dell'acido (s)-tetraidro-a-(1-metiletil)-2-osso-1(2h)-piridinacetico | |
| ITMI20020974A1 (it) | Procedimento per la preparazione dell'acido 4-fluoro-antranilico | |
| EP1632482A4 (en) | INTERMEDIATES AND PROCESS FOR THE PRODUCTION OF OPTICALLY ACTIVE QUINOLONECARBOXYLIC ACID DERIVATIVES | |
| AU2003250142A1 (en) | Method for the production of hydroxyalkyl carbonic acid esters | |
| ATE344800T1 (de) | Substituierte [1,4öbenzodioxin[2,3-eöisoindol- derivaten, ihr verfahren zur herstellung und ihre pharmazeutische zusammensetzungen | |
| AU2003207196A1 (en) | PROCESS FOR PRODUCTION OF OPTICALLY ACTIVE Beta-PHENYLALANINE |